Longer aPTT values in healthy children than in adults: No single cause

被引:20
作者
Gallistl, S
Muntean, W
Leschnik, B
Meyers, W
机构
[1] Graz Univ, Klin Kinder & Jugendheilkunde, Dept Pediat, A-8036 Graz, Austria
[2] Behringwerke AG, D-3550 Marburg, Germany
关键词
aPTT; children; lupus anticoagulants; antiphospholipid antibodies;
D O I
10.1016/S0049-3848(97)00265-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have shown that activated partial thromboplastin time values in children are considerably longer than in adults, but the causes for this observation remained unclear. Therefore, we investigated the correlation between activated partial thromboplastin time values and concentrations of clotting factors, quotients and titers of the tissue thromboplastin inhibition test, and antiphospholipid antibodies in healthy children, children with recurrent infections, and adults. Concentrations of factors VIII, IX, and HMWK were significantly lower in children than in adults. Simple linear regression analysis failed to show a correlation between the concentration of a single clotting factor and the activated partial thromboplastin time values. No significant correlation was found between activated partial thromboplastin time and elevation of the tissue thromboplastin inhibition test quotients or titers, or antiphospholipid antibodies values. The determined activated partial thromboplastin time was best described by a function including all measured coagulation factors. Our study suggests, that no single clotting factor or lupus anticoagulants are responsible for the longer activated partial thromboplastin time in healthy children, but that activated partial thromboplastin prolongation is caused by the combination of several slightly lower clotting factors. (C) 1998 Elsevier Science Ltd.
引用
收藏
页码:355 / 359
页数:5
相关论文
共 20 条
[1]  
ADCOCK DM, 1992, ARCH PATHOL LAB MED, V116, P837
[2]   DEVELOPMENT OF THE HUMAN COAGULATION SYSTEM IN THE FULL-TERM INFANT [J].
ANDREW, M ;
PAES, B ;
MILNER, R ;
JOHNSTON, M ;
MITCHELL, L ;
TOLLEFSEN, DM ;
POWERS, P .
BLOOD, 1987, 70 (01) :165-172
[3]   MATURATION OF THE HEMOSTATIC SYSTEM DURING CHILDHOOD [J].
ANDREW, M ;
VEGH, P ;
JOHNSTON, M ;
BOWKER, J ;
OFOSU, F ;
MITCHELL, L .
BLOOD, 1992, 80 (08) :1998-2005
[4]   DEVELOPMENT OF HEMOSTASIS IN HUMAN FETUS AND NEWBORN INFANT [J].
BLEYER, WA ;
HAKAMI, N ;
SHEPARD, TH .
JOURNAL OF PEDIATRICS, 1971, 79 (05) :838-+
[5]  
BROOKFIELD C, 1995, THROMB HAEMOSTASIS, V73, P1276
[6]   THE ANTIPHOSPHOLIPID SYNDROME AND THE LUPUS ANTICOAGULANT [J].
CAMERON, JS ;
FRAMPTON, G .
PEDIATRIC NEPHROLOGY, 1990, 4 (06) :663-678
[7]  
EBERL W, 1996, PADIATR PRAX, V50, P397
[8]   Lupus anticoagulant and factor XII activity in children with prolonged PTT [J].
Edlinger, G ;
Gallistl, S ;
Muntean, W .
THROMBOSIS RESEARCH, 1996, 83 (05) :403-404
[9]  
EKLUND H, 1970, ACTA PAEDIATR SCAND, V59, P33
[10]  
EXNER T, 1995, THROMB HAEMOSTASIS, V74, P338